Cancer-Drug Shortages Targeted by Stopgap U.S. Approvals
Cancer-drug shortages that have plagued U.S. hospitals are being targeted by Food and Drug Administration decisions, announced today, giving generic-drug makers clearance to provide stopgap replacements.The skinny on diet pills: FDA's OK of Qnexa may open door to other approvals
WASHINGTON The battle of the bulge has been a big, fat failure for U.S. drugmakers. But that hasn t stopped them from trying.